RE: Purdue Says It Will Stop Marketing Its OxyContin To US Doctors

You are viewing a single comment's thread from:

Purdue Says It Will Stop Marketing Its OxyContin To US Doctors

in health •  7 years ago 

Makes me sick that big pharma markets and pushes their products sometimes harder than fast food and potato chip companies.

These drugs should be used out of necessity, not casually pushed onto patients like Tylenol. Painkillers have to be the worst...take that back, ARE the worst of the entire prescription drug world. This is the stuff the government should be regulating and making illegal...but here they are spending millions on the fight against a green plant. All the while, kids are killing themselves and others over painkillers. And big pharma laughs all the way to the bank.

Allow people to grow a plant in their backyard? Oh hell no. Push expensive drugs on the general public in the name of profits...? Oh hell yes.

Great job. Good to know the people at the top have all of us little guys in mind.

Thanks for sharing.

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!
Sort Order:  

Purdue Pharma has announced it will cease marketing its controversial painkiller, OxyContin, to U.S. doctors, marking a significant shift in its approach. The decision comes after years of scrutiny over the opioid crisis, with OxyContin playing a central role in the epidemic. This move highlights a broader trend in pharmaceutical marketing, emphasizing the need for transparency. Industry experts suggest that this decision may affect marketing consulting practices, particularly in how pharmaceutical companies engage with healthcare providers. Marketing consulting will evolve in response to such regulatory changes.

Purdue Pharma announced it will cease marketing its controversial painkiller, OxyContin, to U.S. doctors, marking a significant shift in its business practices. This decision follows years of scrutiny over the role the drug played in the opioid crisis. Purdue's move comes as part of a larger effort to resolve legal challenges and rebuild its public image. In related news, many are now focusing on efforts to extract urls from xml file for better transparency. The company is also working to extract URLs from XML files to improve information accessibility.